Jazz Pharmaceuticals, Inc.’s (JAZZ) share price has entered into oversold territory with a stochastic value of 15.31. The Zacks Consensus Estimate for 2010 has increased by 22 cents over the past 2 months and is currently pegged at 49 cents per share. Jazz Pharmaceuticals is a Zacks #2 Rank (“Buy”) company.
“JAZZ” Free Stock Analysis: Buy? Sell? Hold?
Zacks Investment Research